Chemically modified antibodies as diagnostic imaging agents

Current Opinion in Chemical Biology

Volumn 14, Issue 6, 2010, Pages 803-809

  Day, Jeffrey J ^a   Marquez, Bernadette V ^a   Beck, Heather E ^a   Aweda, Tolulope A ^a   Gawande, Prasad D ^a   Meares, Claude F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMP 449 F 18; INDIUM 111; INDOCYANINE GREEN; LIGAND; MALACHITE GREEN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; DIAGNOSTIC IMAGING; ENZYME ACTIVE SITE; ENZYME ENGINEERING; HUMAN; MOLECULAR PROBE; MOLECULAR RECOGNITION; MUTATION; NONHUMAN; PROTEIN ENGINEERING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; DIAGNOSTIC IMAGING; HUMANS; LIGANDS; ORGAN SPECIFICITY;

EID: 78649901166     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2010.09.015     Document Type: Article

References (41)

1. Senter P.D. Potent antibody drug conjugates for cancer therapy. Curr Op Chem Biol 2009, 13:235-244.
2. Jefferis R., Lund J., Pound J. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev 1998, 163:59-76.
3. 124I-anti-CD20 scFv dimers (diabodies). Protein Eng Des Sel 2010, 23:243-249.
4. Walter R., Press O.W., Pagel J.M. Pretargeted radioimmunotherapy for hematologic and other malignancies. Cancer Biother Radiopharm 2010, 25:125-142.
5. 18F labeling of peptides with a fluoride-aluminum-chelate complex. Bioconjug Chem 2010, 21. (web June 14 2010, doi:2010.1021/bc100137x).
6. 18F-labeled hapten peptide in mice with human tumor xenografts. Mol Cancer Therap 2010, 9:1019-1027.
7. Wei L., Olafsen T., Radu C., Hildebrandt I.J., McCoy M.R., Phelps M.E., Meares C.F., Wu A.M., Czernin J., Weber W.A. Engineered antibody fragments with infinite affinity as reporter genes for PET imaging. J Nucl Med 2008, 49:1828-1835.
8. Aweda T., Beck H.E., Wu A.M., Wei L.H., Weber W.A., Meares C.F. Rates and equilibria for probe capture by an antibody with infinite affinity. Bioconjug Chem 2010, 21:784-791.
9. Corneillie T., Lee K.C., Whetstone P.A., Wong J.P., Meares C.F. Irreversible engineering of the multielement-binding antibody 2D12.5 and its complementary ligands. Bioconjug Chem 2004, 15:1392-1402.
10. Holm L., Moody P., Howarth M. Electrophilic affibodies forming covalent bonds to protein targets. J Biol Chem 2009, 284:32906-32913.
11. Nord K., Nilsson J., Nilsson B., Uhlen M., Nygren P.A. A combinatorial library of an alpha-helical bacterial receptor domain. Protein Eng 1995, 8:601-608.
12. Blackman M., Royzen M., Fox J.M. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand diels-alder reactivity. J Am Chem Soc 2008, 130:13518-13519.
13. Devaraj N., Upadhyay R., Haun J.B., Hilderbrand S.A., Weissleder R. Fast sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. Angew Chem Int Ed 2009, 28:7013-7016.
14. Rossin R., Verkerk P.R., van den Bosch S.M., Vulders R.C.M., Verel I., Lub J., Robillard M.S. In vivo chemistry for pretargeted tumor imaging in live mice. Angew Chem Int Ed 2010, 49:3375-3378.
15. 18F radiolabeling for PET. J Nucl Med 2009, 50:991-998.
16. Goldenberg D.M., Rossi E.A., Sharkey R.M., McBride W.J., Chang C.-H. Multifunctional antibodies by the dock-and-lock method for improved cancer imaging and therapy by pretargeting. J Nucl Med 2008, 49:158-163.
17. Goldenberg D.M., Sharkey R.M., Paganelli G., Barbet J., Chatal J.-F. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy. J Clin Oncol 2006, 24:823-834.
18. Szent-Gyorgyi C., Schmidt B.F., Creeger Y., Fisher G.W., Zakel K.L., Adler S., Fitzpatrick J.A.J., Woolford C.A., Yan Q., Vasilev K.V., et al. Fluorogen-activating single-chain antibodies for imaging cell surface proteins. Nat Biotechnol 2008, 26:235-240.
19. Özhalici-Ünal H., Pow C.L., Marks S.A., Jesper L.D., Silva G.L., Shank N.I., Jones E.W., Burnette J.M., Berget P.B., Armitage B.A. A rainbow of fluoromodules: a promiscuous scfv protein binds to and activates a diverse set of fluorogenic cyanine dyes. J Am Chem Soc 2008, 130:12620-12621.
20. Falco C.N., Dykstra K.M., Yates B.P. Berget PB: scFv-based fluorogen activating proteins and variable domain inhibitors as fluorescent biosensor platforms. Biotechnol J 2009, 4:1328-1336.
21. Ogawa M., Regino C.A.S., Seidel J., Green M.V., Xi W., Williams M., Kosaka N., Choyke P.L., Kobayashi H. Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Bioconjug Chem 2009, 20:2177-2184.
22. van Dijk M., Rijkers D.T.S., Liskamp R.M.J., van Nostrum C.F., Hennink W.E. Synthesis and applications of biomedical and pharmaceutical polymers via click chemistry methodologies. Bioconjug Chem 2009, 20:2001-2016.
23. Kampmeier F., Ribbert M., Nachreiner T., Dembski S., Beaufils F., Brecht A., Barth S. Site-specific covalent labeling of recombinant antibody fragments via fusion to an engineered version of 6-O-alkylguanine DNA alkyltransferase. Bioconjug Chem 2009, 20:1010-1015.
24. Chidley C., Mosiewicz K., Johnsson K. A designed protein for the specific and covalent heteroconjugation of biomolecules. Bioconjug Chem 2008, 19:1753-1756.
25. Gavrilyuk J.I., Wuellner U., Barbas C.F. Beta-Lactam-based approach for the chemical programming of aldolase antibody 38C2. Bioorg Med Chem Lett 2009, 19:1421-1424.
26. Boeggeman E., Ramakrishnan B., Pasek M., Manzoni M., Puri A., Loomis K.H., Waybright T.J., Qasba P.K. Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection. Bioconjug Chem 2009, 20:1228-1236.
27. Ramakrishnan B., Boeggeman E., Manzoni M., Zhu Z., Loomis K., Puri A., Dimitrov D.S., Qasba P.K. Multiple site-specific in vitro labeling of single-chain antibody. Bioconjug Chem 2009, 20:1383-1389.
28. Hofer T., Skeffington L.R., Chapman C.M., Rader C. Molecularly defined antibody conjugation through a selenocysteine interface. Biochemistry 2009, 48:12047-12057.
29. Hofer T., Thomas J.D., Burke T.R., Rader C. An engineered selenocysteine defines a unique class of antibody derivatives. Proc Natl Acad Sci USA 2008, 105:12451-12456.
30. Ban H., Gavrilyuk J., Barbas C.F. Tyrosine bioconjugation through aqueous ene-type reactions: a click-like reaction for tyrosine. J Am Chem Soc 2010, 132:1523-1525.
31. Meares C.F. Targeted instant immunity. Nat Biotechnol 2009, 27:452-453.
32. Popkov M., Gonzalez B., Sinha S.C., Barbas C.F. Instant immunity through chemically programmable vaccination and covalent self-assembly. Proc Natl Acad Sci USA 2009, 106:4378-4383.
33. Xiao J., Chen R., Pawlicki M.A., Tolbert T.J. Targeting a homogeneously glycosylated antibody Fc to bind cancer cells using a synthetic receptor ligand. J Am Chem Soc 2009, 131:13616-13618.
34. Ghetie V., Ward E.S. Multiple roles for the major histocompatibility complex class I-related receptor FcRn. Annu Rev Immunol 2000, 18:739-766.
35. Trüssel S., Dumelin C., Frey K., Villa A., Buller F., Neri D. New strategy for the extension of the serum half-life of antibody fragments. Bioconjug Chem 2009, 20:2286-2292.
36. Dumelin C.E., Trüssel S., Buller F., Trachsel E., Bootz F., Zhang Y., Mannocci L., Beck S.C., Drumea-Mirancea M., Seeliger M.W., et al. A portable albumin binder from a DNA-encoded chemical library. Angew Chem Int Ed 2008, 47:3196-3201.
37. Dennis M., Zhang M., Meng Y.G., Kadkhodayan M., Kirchhofer D., Combs D., Damico L.A. Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem 2002, 277:35035-35043.
38. Dennis M., Jin H., Dugger D., Yang R., McFarland L., Ogasawara A., Williams S., Cole M.J., Ross S., Schwall R. Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent. Cancer Res 2007, 67:254-261.
39. Constantinou A., Chen C., Deonarain M.P. Modulating the pharmacokinetics of therapeutic antibodies. Biotechnol Lett 2010, 32:609-622.
40. Stork R., Campigna E., Robert B., Müller D., Kontermann R.E. Biodistribution of a bispecific single-chain diabody and its half-life extended derivatives. J Biol Chem 2009, 284:25612-25619.
41. Thurber G.M., Schmidt M.M., Wittrup K.D. Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. Adv Drug Deliv Rev 2008, 60:1421-1434.